Zojirushi Corp. saw its net profit climb to 3.53 billion yen for the six-month period ending May 20, up from 3.40 billion yen in the same timeframe last year. The Japanese kitchenware manufacturer bolstered its bottom line as revenue reached 51.21 billion yen, reflecting steady demand for its premium product lineup.
Shimamura Co. reported a significant jump in first-quarter net profit to 12.86 billion yen, up from 10.80 billion yen during the same period last year. The Japanese apparel retailer saw its revenue climb to 181.66 billion yen, signaling robust consumer demand as the company navigated the fiscal quarter ending May 20.
Shares of Alebund Pharmaceuticals more than doubled during their Hong Kong market debut Monday, hitting HK$45.70 against an offering price of HK$22.60. The dramatic opening underscores a resurgence in investor appetite for Chinese biotech firms, bolstered by the company's focus on specialized renal therapies.
Oil prices climbed while Asian equities struggled for direction as renewed fighting near the Strait of Hormuz punctured hopes for regional stability. With one-fifth of global crude supply potentially at risk, investors are discounting the possibility of a swift resolution despite U.S. and Iranian plans to resume peace talks Tuesday.
China’s commerce ministry has placed 20 Japanese entities, including major defense contractors and research institutes, under strict export controls. The move, effective immediately, bans local firms from supplying dual-use technologies, citing national security concerns and the alleged role of these organizations in strengthening Japan’s military capabilities.
Beijing has expanded its export control list to include 20 Japanese entities, effectively severing their access to dual-use Chinese goods. The Monday announcement signals a sharp escalation in regional trade friction, targeting key defense contractors and research institutions under the banner of national security and international non-proliferation standards.
Five Chinese technology and AI companies are targeting a combined $1.3 billion in Hong Kong initial public offerings, betting that investor appetite for innovation remains resilient despite the market volatility triggered by geopolitical tensions between the United States and Iran.
Projecting a significant financial shift, GameStop anticipates adjusted earnings before interest, taxes, depreciation, and amortization will exceed $600 million for the fiscal year ending January 30, 2027. This guidance marks a substantial increase from the $345.4 million reported by the retailer for the preceding fiscal year.
A modest rally across the financial sector is currently balancing competing market forces, as optimism surrounding regional bank earnings contends with cooling sentiment in investment banking. Investors are weighing these gains against a broader climate of uncertainty fueled by stalled tech sector momentum and increased regulatory scrutiny.
The Nasdaq Composite retreated more than 6% from its June 2 peak, as investor enthusiasm for the artificial intelligence sector cooled. Market participants are increasingly questioning the sustainability of the AI boom, forcing a reassessment of valuations across high-growth technology portfolios.
Communications services stocks clawed back recent losses today as market participants recalibrated expectations for consumer spending. The sector’s rebound provided a rare bright spot while energy markets slumped, with oil futures settling at their lowest price point since February 27, the eve of the conflict involving Iran.
Valued at approximately $29 billion, the Chicago-based insurance brokerage Hub International has taken its first formal step toward a public debut. The firm submitted a confidential S-1 filing to regulators, signaling a transition toward the public markets while keeping specific financial disclosures under wraps for now.
Stock traders are pivoting toward the stability of power producers, cooling their exposure to artificial intelligence after recent market swings. This defensive rotation highlights a growing investor preference for tangible utility assets as the broader tech sector faces renewed scrutiny and unpredictable price action in the current trading climate.
The Paris Judicial Court has dismissed a legal challenge from activist groups and the City of Paris, which aimed to force TotalEnergies to halt new oil and gas developments. The ruling affirmed that the court lacks the mandate to dictate specific climate targets or production strategies for the energy giant.
Packaging giant International Paper is shuttering three manufacturing plants and ending preprint operations at a fourth facility by the end of the third quarter. The move, aimed at lowering costs and consolidating regional capacity, follows a broader pattern of asset rationalization for the company throughout the current fiscal year.
The U.S. Food and Drug Administration has granted approval to Viridian Therapeutics for Lumvoa, a new therapy targeting thyroid eye disease. This decision marks a significant shift in clinical options, as the drug becomes the first treatment authorized to address both the active and chronic stages of the condition.
With plans to raise roughly $256.9 million, Cayman Islands-based AMR Resources Acquisition Corp. filed for an initial public offering on Friday. The blank-check company intends to leverage its Nasdaq debut to hunt for acquisition targets within the critical minerals sector, spanning everything from exploration to recycling.
A modest recovery in precious metals markets offered a reprieve for raw material producers this week, even as silver futures finalized their steepest weekly decline since 2018. The rebound comes alongside a structural shift at BHP Group, which is splitting its regional management to accelerate growth across the Americas.
Threats of escalating trade tensions between the United States and Europe sent industrial and transportation stocks into a slump Friday. The market reaction followed a week of conflicting economic signals, as traders weighed cooling inflation indicators against the prospect of a renewed standoff over international tech taxation.
Under a court-mandated restructuring, Corporacion America Airports is set to participate in a fast-track tender to acquire the remaining stake in Inframerica Concessionaria do Aeroporto de Brasilia. The move follows an amendment agreement with Brazilian authorities that effectively clears the path for the firm to consolidate its ownership of the airport.
Months after entering Chapter 11 bankruptcy, Yellow Corp. has confirmed a significant security breach. On March 27, 2025, unauthorized actors infiltrated the company's network and exfiltrated sensitive files, forcing the defunct carrier to issue a public notice because it could no longer verify contact information for the victims.
A broader market rotation into underperforming sectors sent health-care stocks climbing this week. Investors moved away from high-growth leaders, favoring pharmaceutical firms that showed promise in new drug development and regulatory milestones, even as antitrust scrutiny and authorization hurdles complicated the landscape for other industry players.
Falling oil futures are providing a rare tailwind for the consumer sector, as the prospect of cheaper gasoline helps stabilize sentiment after a period of historic pessimism. Investors are recalibrating their expectations for retail spending power while simultaneously weighing new regulatory scrutiny hitting major European e-commerce players.
Universe Pharmaceuticals has finalized an agreement to acquire Best Praise International Limited for $10.8 million in stock. The move secures control over five Chinese patents, marking a strategic pivot for the company as it seeks to expand its footprint in neurodegenerative research and advanced drug delivery systems.
Biotechnology firm Scancell Holdings has entered preliminary negotiations to acquire Neuphoria Therapeutics, a move that would facilitate Scancell’s debut on the Nasdaq exchange. The companies confirmed the ongoing discussions late Friday, though both sides cautioned that a final agreement remains subject to further deliberation and regulatory approval.
The Food and Drug Administration has blocked approval for LNTH-2501, a diagnostic agent intended for neuroendocrine tumor detection, citing unresolved manufacturing deficiencies at a third-party facility. Lantheus Holdings confirmed the setback Friday, marking a significant hurdle for one of its primary late-stage oncology candidates.
A $50 million transaction has effectively removed City Center from Kite Realty Group’s portfolio. The 1.1 million-square-foot mixed-use asset in White Plains, New York, anchored by major retail tenants Target and Shop Rite, was offloaded as the company continues to refine its holdings through an aggressive capital recycling strategy.
For the roughly 30% of psoriasis patients who develop symptoms before turning 18, relief options have expanded. The FDA has officially cleared AbbVie’s Skyrizi, known chemically as risankizumab-rzaa, for pediatric use, marking a shift in how clinicians can manage moderate-to-severe plaque psoriasis and active psoriatic arthritis in younger populations.
Effective July 1, Kroger Chairman Ronald Sargent will step away from his employee status at the supermarket chain. While vacating his executive duties, the former Staples chief executive will maintain his presence on the board, transitioning into a non-executive role to continue his oversight of the company.
Universe Pharmaceuticals has reached an agreement to acquire Best Praise International Limited in an all-stock transaction valued at $10.8 million. The move, which involves issuing 4.8 million shares of common stock, aims to bolster the company’s intellectual property portfolio ahead of the deal's expected third-quarter closing.
